| P2093 | author name string | Paolo Raggi | |
| | C Michael Stein | |
| | Cecilia P Chung | |
| | Ingrid Avalos | |
| P2860 | cites work | Prediction of Coronary Heart Disease Using Risk Factor Categories | Q22241923 |
| | Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study | Q24812262 |
| | Atherosclerosis — An Inflammatory Disease | Q26776972 |
| | Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report | Q27861020 |
| | C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women | Q29616306 |
| | Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. | Q33898507 |
| | Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis | Q34182804 |
| | Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial | Q34327988 |
| | The mortality of rheumatoid arthritis | Q34338843 |
| | Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis | Q35630128 |
| | Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. | Q36031031 |
| | An evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus Conference | Q36332617 |
| | Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years | Q40213181 |
| | Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. | Q44068950 |
| | Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis | Q44652560 |
| | Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis | Q44951945 |
| | Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study | Q44973310 |
| | Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee | Q45002081 |
| | Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease | Q45151895 |
| | Effect of glucocorticoids on the arteries in rheumatoid arthritis | Q45184227 |
| | Cardiac risk factor awareness and management in patients with systemic lupus erythematosus | Q45184356 |
| | Preclinical carotid atherosclerosis in patients with rheumatoid arthritis | Q46954458 |
| | Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis | Q48502988 |
| | Quantification of coronary artery calcium using ultrafast computed tomography. | Q52867038 |
| | Cardiovascular risk scores and the presence of subclinical coronary artery atherosclerosis in women with systemic lupus erythematosus. | Q53514044 |
| | Impaired glucose handling in active rheumatoid arthritis: relationship to peripheral insulin resistance. | Q54389817 |
| | Cardiovascular mortality in patients with rheumatoid arthritis | Q69586053 |
| | Cause of death in rheumatoid arthritis | Q71349315 |
| | Cardiovascular mortality in women with rheumatoid arthritis | Q72057364 |
| | Length of life and cause of death in rheumatoid arthritis | Q73268669 |
| | Problems on the pathway from risk assessment to risk reduction | Q74593960 |
| | High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors | Q77406810 |
| | Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease | Q79354392 |
| | Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis | Q79698753 |
| | Antirheumatic drug use and the risk of acute myocardial infarction | Q80016233 |
| | Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors | Q81300622 |
| | Use of low-dose glucocorticoids and the risk of cardiovascular morbidity and mortality in rheumatoid arthritis: what is the true direction of effect? | Q81312678 |
| | Cardiovascular death in rheumatoid arthritis: a population-based study | Q81484761 |
| | When is a patient with rheumatoid arthritis at risk for cardiovascular disease? | Q82500246 |
| P433 | issue | 8 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| | atherosclerosis | Q12252367 |
| P304 | page(s) | 1228-1233 | |
| P577 | publication date | 2007-02-02 | |
| P1433 | published in | Clinical Rheumatology | Q15754927 |
| P1476 | title | Atherosclerosis and inflammation: insights from rheumatoid arthritis | |
| P478 | volume | 26 | |